Screening for prostate cancer: US preventive services task force recommendation statement

被引:445
作者
Calonge N. [1 ]
Petitti D.B. [2 ]
Dewitt T.G. [3 ]
Dietrich A.J. [4 ]
Gregory K.D. [5 ]
Harris R. [6 ]
Isham G.J. [7 ]
Lefevre M.L. [8 ]
Leipzig R. [9 ]
Loveland-Cherry C. [10 ]
Marion L.N. [11 ]
Melnyk B. [12 ]
Moyer V.A. [13 ]
Ockene J.K. [14 ]
Sawaya G.F. [15 ]
Yawn B.P. [16 ]
机构
[1] Agcy Healthcare Res & Qual, US Prevent Serv Task Force, Rockville, MD USA
关键词
D O I
10.7326/0003-4819-149-3-200808050-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Description: Update of the 2002 U. S. Preventive Services Task Force (USPSTF) recommendation statement about screening for prostate cancer. Methods: The USPSTF evaluated randomized, controlled trials of the benefits of prostate cancer screening; cohort and cross-sectional studies of the psychological harms of false-positive prostate-specific antigen test results; and evidence on the natural history of prostate-specific antigen-detected prostate cancer to address previously identified gaps in the evidence from the 2002 USPSTF recommendation. Recommendations: Current evidence is insufficient to assess the balance of benefits and harms of screening for prostate cancer in men younger than age 75 years (I statement). Do not screen for prostate cancer in men age 75 years or older (Grade D recommendation).
引用
收藏
页码:185 / 191
页数:7
相关论文
共 21 条
[1]  
*AM AC FAM PHYS, 2008, SUMM REC CLIN PREV S
[2]  
*AM UR ASS, 2000, ONCOLOGY, V14, P277
[3]  
*AM UR ASS, 2000, ONCOLOGY HUNTINGT, V14, P280
[4]  
[Anonymous], 2008, Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer
[5]  
[Anonymous], 2000, Oncology
[6]   Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer - Results from a prospective, population-based randomized controlled trial [J].
Aus, Gunnar ;
Bergdahl, Suante ;
Lodding, Par ;
Liija, Hans ;
Hugosson, Jonas .
EUROPEAN UROLOGY, 2007, 51 (03) :659-664
[7]   Radical prostatectomy versus watchful waiting in early prostate cancer [J].
Bill-Axelson, A ;
Holmberg, L ;
Ruutu, M ;
Häggman, M ;
Andersson, SO ;
Bratell, S ;
Spångberg, A ;
Busch, C ;
Nordling, S ;
Garmo, H ;
Palmgren, J ;
Adami, HO ;
Norlén, BJ ;
Johansson, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (19) :1977-1984
[8]  
Coley CM, 1997, ANN INTERN MED, V126, P480
[9]  
Etzioni R, 2002, J NATL CANCER I, V94, P981
[10]   A PROSPECTIVE EVALUATION OF PLASMA PROSTATE-SPECIFIC ANTIGEN FOR DETECTION OF PROSTATIC-CANCER [J].
GANN, PH ;
HENNEKENS, CH ;
STAMPFER, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (04) :289-294